Dr
Nienke
Lubben

Partner & Patent Attorney

York Office The Hague Office

Life sciences

Telephone. +44(0) 1904 732 120
Mobile. +44(0) 777 265 2294
Email. [email protected]

Experience

Nienke's portfolio encompasses a diverse range of biological subject matter including: cell therapy, biomarkers, biosimilars, antibodies, immunology, therapeutics, cell biology, biotechnology, enzymology, diagnostics and biopharmaceuticals. She handles all patent related matters including: preparing patent applications, prosecuting patent applications before the EPO and UKIPO, managing worldwide patent prosecution, strategic reviews, due diligence, and validity opinions.

Nienke has considerable experience working with universities and spin-out companies and can bring a depth of commercially relevant advice from her experience in working for a start-up biotech company prior to entering the profession. Nienke also works with SMEs and large multinational companies. Her pragmatic advice is appropriately tailored to her client's individual needs.

Nienke has represented clients before the Oppositions Division of the EPO and has a particular interest in opposition matters. Her ability to quickly assimilate and utilise scientific literature to the benefit of her clients is a key strength during oral proceedings before both the Opposition Division and the Boards of Appeal of the EPO.

Nienke qualified as a Patent Attorney in 2012 and was awarded the Strode Prize for obtaining the highest mark in the UK finals law exam, P2. She also holds a Post-Graduate Certificate in Intellectual Property Law from the Queen Mary, University of London, obtained with distinction. She obtained her PhD from the University of Cambridge in Infection and Immunity and graduated with a First Class Honours degree in Biological Sciences (Genetics) from the University of Leicester with the highest mark in her year.

Qualifications

Patent Attorney

Chartered (UK)
European


BSC

Biological Sciences (genetics)

PHD

Infection and Immunity

Recognition

MIP IP Rising Star 2019/20

MIP IP Rising Star 2018/19

Publications

MIP IP Rising Stars 2019/20

View publication online

Related News

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details
Event - 10th March 2022

Manufacturing & Supply Chain Conference 2022

HGF Patent Attorney Dr Robert Weinert-Aplin is attending and speaking at the Manufacturing & Supply Chain Conference on 10th March 2022 in Milton Keynes, UK. The Manufacturing & Supply Chain …

Event details

The Microbiome Times: ELIGO v SNIPR: a reflection on IP strategies in a competitive environment

HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in …

Read article

UPC could open its doors in 2022

With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.